Methods | Randomised trial comparing carbohydrate drink the evening before surgery and 30 days postoperative oral supplements to regular eating in patients undergoing hepatic resections for liver tumors. Geographical location Scotland and the Netherlands. Paper published 2010. |
|
Participants | Inclusion criteria: Resectable benign or malignant liver tumor, age 18‐80, BMI 18‐30 scheduled for surgery between July 2006 and June 2008. Exclusion criteria: Pre‐existing conditions limiting mobility, underlying cirrhosis, history of liver resection, need for bile duct excision, need for central or extended hepatectomy. |
|
Interventions | Intervention group received 400 ml commercial loading drink (Nutricia Preop®) 10 PM/4AM preop; 400 ml commerical supplement (Nutricia Fortisip®) bid postop (for one month). Control group received regular diet. |
|
Outcomes | Primary outcome was time to passage of stool; secondary outcomes included mortality, postoperative complications. duration of hospitalization, rehospitalizations, and reoperations | |
Category of study | Supplements/Surgical. | |
Sample size calculation | Yes, but powered to see difference in time of appearance of stool. | |
Full paper or abstract only | Full paper. | |
Notes | Trial had factorial design in which patients also randomised to receiving or not receiving laxative (magnesium oxide) during hospitalization; data in paper presented only for combination groups (supplements versus no supplements and laxative versus no laxative). E‐mail request for further information sent to Dr Hendry on 2/17/12 at paul.hendry@ed.ac.uk., but no further information has been received as of March 20, 2012. | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Block randomisation with random number table. |
Allocation concealment (selection bias) | Low risk | Sealed opaque envelopes (not noted if serially numbered, but accepted as adequate concealment of allocation). |
Blinding (performance bias and detection bias) All outcomes | High risk | Not blinded. |
Incomplete outcome data (attrition bias) All outcomes | High risk | 6/74 patients dropped out of trial by investigators because the planned resection could not be accomplished and palliative surgery done instead; no indication how many from each group. However, given the block design and the fact that 30 treated versus 38 control patients were compared, it is likely that most, or even all, came from treatment arm (which may have resulted in the removal of higher risk patients). |
Selective reporting (reporting bias) | Low risk | Mortality and morbidity reported, but data presented for individuals who also did, or did not, receive laxatives postoperatively. |
Other bias | Unclear risk | Unclear funder although commercial company provided the nutrient solutions. |
Intent to treat analysis | High risk | Unknown from which arm each dropout came, so intent to treat analysis could not be done. |
Baseline imbalance? | Low risk | No differences in baseline characteristics of the per protocol arms. |
Early stopping? | Low risk | Sample size calculation indicated need for 14 patients for each of the four arms, and more than that reported. |